EnClear Therapies Revenue and Competitors

Boston, MA USA

Location

N/A

Total Funding

Estimated Revenue & Valuation

  • EnClear Therapies's estimated annual revenue is currently $3.8M per year.(i)
  • EnClear Therapies's estimated revenue per employee is $251,000

Employee Data

  • EnClear Therapies has 15 Employees.(i)
  • EnClear Therapies grew their employee count by 25% last year.

EnClear Therapies's People

NameTitleEmail/Phone
1
President & CEO, Co-FounderReveal Email/Phone
2
Scientific Adviser, Co-FounderReveal Email/Phone
3
COOReveal Email/Phone
4
Senior Engineering Program ManagerReveal Email/Phone
5
R&D EngineerReveal Email/Phone
6
Regulatory LeadReveal Email/Phone
7
Mechanical EngineerReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$11M4413%N/AN/A
#2
$11M4429%N/AN/A
#3
$4.3M170%N/AN/A
#4
$3.8M15-29%N/AN/A
#5
$5630M9122-11%$450MN/A
#6
$4.3M170%N/AN/A
#7
$4M16-72%$23.5MN/A
#8
$44.4M1779%N/AN/A
#9
$45.7M1820%N/AN/A
#10
$15M798%$105.2MN/A
Add Company

What Is EnClear Therapies?

At EnClear Therapies, we are combining Bioscience & Med-tech expertise to develop solutions that improve and extend the lives of patients with CNS disease. The team at EnClear is developing systems and medical interventions that Access, Recirculate & Modify CSF for: › Targeted removal of toxicity from CSF correlated to neurodegenerative disease progression. › Continuous localized delivery of therapeutics & monitoring of CSF to ensure effective and personalized therapy.

keywords:N/A

N/A

Total Funding

15

Number of Employees

$3.8M

Revenue (est)

25%

Employee Growth %

N/A

Valuation

N/A

Accelerator

EnClear Therapies News

2022-04-06 - BioWorld MedTech Patent Highlights: Week 13

Assignee: Alessa Therapeutics Inc; University of California. Inventors: Desai, Pujan; Hall, Keith; Maroney, ... Assignee: EnClear Therapies.

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$2.6M176%N/A
#2
$1.5M17-6%N/A
#3
$3.5M18-36%N/A
#4
$1.1M1912%N/A
#5
$3.1M220%N/A